FindTrial
Sign In

The role of CGRP in psoriasis

The role of CGRP and CALCA T-692C single-nucleotide polymorphism in psoriasis vulgaris

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RCC-12002420
Enrollment
Unknown
Registered
2012-07-18
Start date
2009-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

psoriasis:none
Healthy voluenteers:Nil

Sponsors

Xiangya Hospital of Centrol South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 59 Years

Inclusion criteria

Inclusion criteria: Psoriasis detected by clinical symptom, biochemistry and pathematology; Healthy volunteer determined by medical examination

Exclusion criteria

Exclusion criteria: Psoriasis patients with any other diseases

Design outcomes

Primary

MeasureTime frame
calcitonin gene-related peptide;CALCA T-692C Genotyping;—

Countries

China

Contacts

Public ContactXiang Chen
lidaimaill@gmail.com+86 0731 84327128

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026